MIAT and cardiac hypertrophy: MIAT is a lncRNA that was initially identified to be associated with myocardial infarction [17], but recent studies have implicated that MIAT is also involved in paranoid schizophrenia [18], diabetes-related diseases [19, 20], neurovascular dysfunction [21], cardiac hypertrophy [22], and cancer [23, 24].